IL6 and obesity disorder: We found that the treatment with IAP preferentially inhibited the plasma levels of proinflammatory cytokines TNF-α and IL-6 compared to control colitis mice fed with diet-induced obesity, indicating the potent anti-inflammatory potential of this enzyme especially in obese mice [20].